IsoPlexis recently presented proof-of-concept data from Duomic, its novel functional proteomic + transcriptomic platform.
IsoPlexis has demonstrated the ability to simultaneously measure functional protein and gene expression levels from the same cell, with the goal of identifying which genes and gene pathways have a downstream impact on protein heterogeneity in these cells.